CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR
Abstract
CUL4A has been proposed as oncogene in several types of human cancer, but its clinical significance and functional role in human non-small cell lung cancer (NSCLC) remain unclear. Expression level of CUL4A was examined by RT-PCR and Western blot. Forced expression of CUL4A was mediated by retroviruses, and CUL4A silencing by shRNAs expressing lentiviruses. Growth capacity of lung cancer cells was measured by MTT in vitro and tumorigenesis in vivo, respectively. We found that CUL4A was highly expressed in human lung cancer tissues and lung cancer cell lines, and this elevated expression positively correlated with disease progression and prognosis. Overexpression of CUL4A in human lung cancer cell lines increased cell proliferation, inhibited apoptosis, and subsequently conferred resistance to chemotherapy. On other hand, silencing CUL4A expression in NSCLC cells reduced proliferation, promoted apoptosis and resulted in tumor growth inhibition in cancer xenograft model. Mechanistically, we revealed CUL4A regulated EGFR transcriptional expression and activation, and subsequently activated AKT. Targeted inhibition of EGFR activity blocked these CUL4A induced oncogenic activities. In conclusion, our results highlight the significance of CUL4A in NSCLC and suggest that CUL4A could be a promising therapy target and a potential biomarker for prognosis and EGFR target therapy in NSCLCmore »
- Authors:
-
- Shandong Univ., Jinan (China)
- The Fifth People's Hospital (China)
- Shandong Cancer and Hospital Inst. (China)
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Publication Date:
- Research Org.:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Biological and Environmental Research (BER)
- OSTI Identifier:
- 1257383
- Grant/Contract Number:
- AC02-05CH11231
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Molecular Cancer
- Additional Journal Information:
- Journal Volume: 13; Journal Issue: 1; Journal ID: ISSN 1476-4598
- Publisher:
- BioMed Central
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES; Erlotinib; EGFR; Lung cancer; CUL4A
Citation Formats
Wang, Yunshan, Zhang, Pengju, Liu, Ziming, Wang, Qin, Wen, Mingxin, Wang, Yuli, Yuan, Hongtu, Mao, Jian-Hua, and Wei, Guangwei. CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR. United States: N. p., 2014.
Web. doi:10.1186/1476-4598-13-252.
Wang, Yunshan, Zhang, Pengju, Liu, Ziming, Wang, Qin, Wen, Mingxin, Wang, Yuli, Yuan, Hongtu, Mao, Jian-Hua, & Wei, Guangwei. CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR. United States. https://doi.org/10.1186/1476-4598-13-252
Wang, Yunshan, Zhang, Pengju, Liu, Ziming, Wang, Qin, Wen, Mingxin, Wang, Yuli, Yuan, Hongtu, Mao, Jian-Hua, and Wei, Guangwei. Fri .
"CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR". United States. https://doi.org/10.1186/1476-4598-13-252. https://www.osti.gov/servlets/purl/1257383.
@article{osti_1257383,
title = {CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR},
author = {Wang, Yunshan and Zhang, Pengju and Liu, Ziming and Wang, Qin and Wen, Mingxin and Wang, Yuli and Yuan, Hongtu and Mao, Jian-Hua and Wei, Guangwei},
abstractNote = {CUL4A has been proposed as oncogene in several types of human cancer, but its clinical significance and functional role in human non-small cell lung cancer (NSCLC) remain unclear. Expression level of CUL4A was examined by RT-PCR and Western blot. Forced expression of CUL4A was mediated by retroviruses, and CUL4A silencing by shRNAs expressing lentiviruses. Growth capacity of lung cancer cells was measured by MTT in vitro and tumorigenesis in vivo, respectively. We found that CUL4A was highly expressed in human lung cancer tissues and lung cancer cell lines, and this elevated expression positively correlated with disease progression and prognosis. Overexpression of CUL4A in human lung cancer cell lines increased cell proliferation, inhibited apoptosis, and subsequently conferred resistance to chemotherapy. On other hand, silencing CUL4A expression in NSCLC cells reduced proliferation, promoted apoptosis and resulted in tumor growth inhibition in cancer xenograft model. Mechanistically, we revealed CUL4A regulated EGFR transcriptional expression and activation, and subsequently activated AKT. Targeted inhibition of EGFR activity blocked these CUL4A induced oncogenic activities. In conclusion, our results highlight the significance of CUL4A in NSCLC and suggest that CUL4A could be a promising therapy target and a potential biomarker for prognosis and EGFR target therapy in NSCLC patients.},
doi = {10.1186/1476-4598-13-252},
journal = {Molecular Cancer},
number = 1,
volume = 13,
place = {United States},
year = {Fri Nov 21 00:00:00 EST 2014},
month = {Fri Nov 21 00:00:00 EST 2014}
}
Web of Science
Works referenced in this record:
The Intrinsic Apoptosis Pathways as a Target in Anticancer Therapy
journal, May 2012
- Jendrossek, Verena
- Current Pharmaceutical Biotechnology, Vol. 13, Issue 8
The CUL4 Enigma: Culling DNA Repair Factors
journal, May 2009
- Sugasawa, Kaoru
- Molecular Cell, Vol. 34, Issue 4
Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes
journal, December 2009
- Melchor, Lorenzo; Saucedo-Cuevas, Laura Paula; Muñoz-Repeto, Iván
- Breast Cancer Research, Vol. 11, Issue 6
Lung tumourigenesis in a conditional Cul4A transgenic mouse model : Cul4A in lung tumourigenesis
journal, May 2014
- Yang, Yi-Lin; Hung, Ming-Szu; Wang, Yang
- The Journal of Pathology, Vol. 233, Issue 2
CUL4A Induces Epithelial–Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression
journal, December 2013
- Wang, Yunshan; Wen, Mingxin; Kwon, Yongwon
- Cancer Research, Vol. 74, Issue 2
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer
journal, July 2013
- Traynor, Anne M.; Weigel, Tracey L.; Oettel, Kurt R.
- Lung Cancer, Vol. 81, Issue 1
Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma
journal, March 2012
- Birner, Peter; Schoppmann, Alexandra; Schindl, Monika
- Journal of Clinical Pathology, Vol. 65, Issue 6
Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of theDP1 gene in the 13q34 amplicon
journal, April 1999
- Shinomiya, Takashi; Mori, Toshiki; Ariyama, Yoji
- Genes, Chromosomes and Cancer, Vol. 24, Issue 4
EGFR lung cancer mutants get specialized
journal, September 2013
- Littlefield, P.; Jura, N.
- Proceedings of the National Academy of Sciences, Vol. 110, Issue 38
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study
journal, October 2014
- Seto, Takashi; Kato, Terufumi; Nishio, Makoto
- The Lancet Oncology, Vol. 15, Issue 11
An Evolutionarily Conserved Function of Proliferating Cell Nuclear Antigen for Cdt1 Degradation by the Cul4-Ddb1 Ubiquitin Ligase in Response to DNA Damage
journal, January 2006
- Hu, J.
- Journal of Biological Chemistry, Vol. 281, Issue 7
TFDP1, CUL4A, andCDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas
journal, June 2002
- Yasui, Kohichiroh; Arii, Shigeki; Zhao, Chen
- Hepatology, Vol. 35, Issue 6
Cancer cell apoptotic pathways mediated by PEDF: prospects for therapy
journal, October 2009
- Broadhead, Matthew L.; Dass, Crispin R.; Choong, Peter F. M.
- Trends in Molecular Medicine, Vol. 15, Issue 10
Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics
journal, January 2010
- Raine, R.; Wong, W.; Scholes, S.
- BMJ, Vol. 340, Issue jan14 1
Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients?
journal, August 2013
- Rossi, Antonio; Pasquale, Raffaella; Esposito, Claudia
- Cancer Treatment Reviews, Vol. 39, Issue 5
CUL4A Abrogation Augments DNA Damage Response and Protection against Skin Carcinogenesis
journal, May 2009
- Liu, Liren; Lee, Sharrell; Zhang, Jianxuan
- Molecular Cell, Vol. 34, Issue 4
Cul4A is an oncogene in malignant pleural mesothelioma
journal, February 2011
- Hung, Ming-Szu; Mao, Jian-Hua; Xu, Zhidong
- Journal of Cellular and Molecular Medicine, Vol. 15, Issue 2
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth
journal, September 2013
- Kim, T. Y.; Jackson, S.; Xiong, Y.
- Proceedings of the National Academy of Sciences, Vol. 110, Issue 42
Epidermal Growth Factor Receptor Protects Proliferating Cell Nuclear Antigen from Cullin 4A Protein-mediated Proteolysis
journal, June 2012
- Lo, Yuan-Hung; Ho, Po-Chun; Wang, Shao-Chun
- Journal of Biological Chemistry, Vol. 287, Issue 32
An Evolutionarily Conserved Function of Proliferating Cell Nuclear Antigen for Cdt1 Degradation by the Cul4-Ddb1 Ubiquitin Ligase in Response to DNA Damage
text, January 2006
- Jian, Hu,; Yue, Xiong,
- The University of North Carolina at Chapel Hill University Libraries
Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer
journal, March 2012
- Ren, Shancheng; Xu, Chuanliang; Cui, Zilian
- Journal of Molecular Medicine, Vol. 90, Issue 10
Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy
journal, August 2013
- Yamashita, Fumie; Azuma, Koichi; Yoshida, Tsukasa
- PLoS ONE, Vol. 8, Issue 8
A Cul4 E3 Ubiquitin Ligase Regulates Histone Hand-Off during Nucleosome Assembly
journal, November 2013
- Han, Junhong; Zhang, Hui; Zhang, Honglian
- Cell, Vol. 155, Issue 4
Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non-small cell lung cancer
journal, January 2013
- Hagiwara, Koichi; Kobayashi, Kunihiko
- Cancer Science, Vol. 104, Issue 3
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
journal, July 2013
- Liu, Xiaoqing; Lu, Yachao; Zhu, Guanshan
- Journal of Clinical Pathology, Vol. 66, Issue 12
Genetic Alterations in Childhood Medulloblastoma Analyzed by Comparative Genomic Hybridization
journal, January 2002
- Michiels, Erna M. C.; Weiss, Marjan M.; Hoovers, Jan M. N.
- Journal of Pediatric Hematology/Oncology, Vol. 24, Issue 3
Cancer statistics, 2012
journal, January 2012
- Siegel, Rebecca; Naishadham, Deepa; Jemal, Ahmedin
- CA: A Cancer Journal for Clinicians, Vol. 62, Issue 1
Role of Epidermal Growth Factor Receptor Inhibitors in Epidermal Growth Factor Receptor Wild-Type Non–Small-Cell Lung Cancer
journal, March 2013
- Laurie, Scott A.; Goss, Glenwood D.
- Journal of Clinical Oncology, Vol. 31, Issue 8
Les thérapies ciblées dans la cancérologie digestive
journal, August 2012
- Boutayeb, S.; Bensouda, Y.; Fadoulkhair, Z.
- Pathologie Biologie, Vol. 60, Issue 4
Chemotherapeutic Targeting of Cell Death Pathways
journal, March 2012
- Mansilla, Sylvia; Llovera, Laia; Portugal, Jose
- Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, Issue 3
Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis
journal, June 2006
- Li, Binghui; Jia, Nan; Kapur, Reuben
- Blood, Vol. 107, Issue 11
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
journal, July 2013
- Noto, Alessia; De Vitis, Claudia; Roscilli, Giuseppe
- Oncotarget, Vol. 4, Issue 8
Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications
journal, June 2000
- Dohna, Martha; Reincke, Martin; Mincheva, Antoaneta
- Genes, Chromosomes and Cancer, Vol. 28, Issue 2
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth
text, January 2013
- L., Tran, N.; Y. -J., Bang,; G., Whitsett, T.
- The University of North Carolina at Chapel Hill University Libraries
A Cul4 E3 Ubiquitin Ligase Regulates Histone Hand-Off during Nucleosome Assembly
journal, November 2013
- Han, Junhong; Zhang, Hui; Zhang, Honglian
- Cell, Vol. 155, Issue 4
Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients?
journal, August 2013
- Rossi, Antonio; Pasquale, Raffaella; Esposito, Claudia
- Cancer Treatment Reviews, Vol. 39, Issue 5
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer
journal, July 2013
- Traynor, Anne M.; Weigel, Tracey L.; Oettel, Kurt R.
- Lung Cancer, Vol. 81, Issue 1
Les thérapies ciblées dans la cancérologie digestive
journal, August 2012
- Boutayeb, S.; Bensouda, Y.; Fadoulkhair, Z.
- Pathologie Biologie, Vol. 60, Issue 4
What new therapeutic targets exist for EGFR-mutant NSCLC?
journal, October 2014
- Rosell, Rafael
- The Lancet Oncology, Vol. 15, Issue 11
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth
journal, September 2013
- Kim, T. Y.; Jackson, S.; Xiong, Y.
- Proceedings of the National Academy of Sciences, Vol. 110, Issue 42
EGFR lung cancer mutants get specialized
journal, September 2013
- Littlefield, P.; Jura, N.
- Proceedings of the National Academy of Sciences, Vol. 110, Issue 38
Cullin 4A-mediated Proteolysis of DDB2 Protein at DNA Damage Sites Regulates in Vivo Lesion Recognition by XPC
journal, March 2006
- El-Mahdy, Mohamed A.; Zhu, Qianzheng; Wang, Qi-en
- Journal of Biological Chemistry, Vol. 281, Issue 19
CDK Inhibitor p21 Is Degraded by a Proliferating Cell Nuclear Antigen-coupled Cul4-DDB1 Cdt2 Pathway during S Phase and after UV Irradiation
journal, August 2008
- Nishitani, Hideo; Shiomi, Yasushi; Iida, Hiroka
- Journal of Biological Chemistry, Vol. 283, Issue 43
Genetic Alterations in Childhood Medulloblastoma Analyzed by Comparative Genomic Hybridization
journal, January 2002
- Michiels, Erna M. C.; Weiss, Marjan M.; Hoovers, Jan M. N.
- Journal of Pediatric Hematology/Oncology, Vol. 24, Issue 3
Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics
journal, January 2010
- Raine, R.; Wong, W.; Scholes, S.
- BMJ, Vol. 340, Issue jan14 1
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
journal, July 2013
- Liu, Xiaoqing; Lu, Yachao; Zhu, Guanshan
- Journal of Clinical Pathology, Vol. 66, Issue 12
Cul4A Physically Associates with MDM2 and Participates in the Proteolysis of p53
journal, November 2004
- Nag, Alo; Bagchi, Srilata; Raychaudhuri, Pradip
- Cancer Research, Vol. 64, Issue 22
Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis
journal, June 2006
- Li, Binghui; Jia, Nan; Kapur, Reuben
- Blood, Vol. 107, Issue 11
New Targetable Oncogenes in Non–Small-Cell Lung Cancer
journal, March 2013
- Oxnard, Geoffrey R.; Binder, Adam; Jänne, Pasi A.
- Journal of Clinical Oncology, Vol. 31, Issue 8
An Evolutionarily Conserved Function of Proliferating Cell Nuclear Antigen for Cdt1 Degradation by the Cul4-Ddb1 Ubiquitin Ligase in Response to DNA Damage
text, January 2006
- Jian, Hu,; Yue, Xiong,
- The University of North Carolina at Chapel Hill University Libraries
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
journal, July 2013
- Noto, Alessia; De Vitis, Claudia; Roscilli, Giuseppe
- Oncotarget, Vol. 4, Issue 8
The Intrinsic Apoptosis Pathways as a Target in Anticancer Therapy
journal, May 2012
- Jendrossek, Verena
- Current Pharmaceutical Biotechnology, Vol. 13, Issue 8
Cancer statistics, 2012
journal, January 2012
- Siegel, Rebecca; Naishadham, Deepa; Jemal, Ahmedin
- CA: A Cancer Journal for Clinicians, Vol. 62, Issue 1
Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease
journal, January 2012
- Lee, Jennifer; Zhou, Pengbo
- Frontiers in Oncology, Vol. 2
Lung Cancer Genotype-Based Therapy and Predictive Biomarkers: Present and Future
journal, December 2012
- Cagle, Philip T.; Allen, Timothy Craig
- Archives of Pathology & Laboratory Medicine, Vol. 136, Issue 12
Works referencing / citing this record:
HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma
journal, October 2015
- Lv, Xiupeng; Li, Linlin; Lv, Li
- Journal of Experimental & Clinical Cancer Research, Vol. 34, Issue 1
Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression
journal, October 2015
- Ji, Xuening; Jin, Shi; Qu, Xiaotong
- BMC Cancer, Vol. 15, Issue 1
The cullin4A is up-regulated in chronic obstructive pulmonary disease patient and contributes to epithelial-mesenchymal transition in small airway epithelium
journal, May 2019
- Ren, Yidan; Zhang, Yi; Fan, Lixia
- Respiratory Research, Vol. 20, Issue 1
Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas
journal, March 2017
- Yan, Hong; Bi, Lei; Wang, Yunshan
- Scientific Reports, Vol. 7, Issue 1
KDM6B promotes ovarian cancer cell migration and invasion by induced transforming growth factor‐β1 expression
journal, August 2018
- Liang, Shumei; Yao, Qingmin; Wei, Deying
- Journal of Cellular Biochemistry, Vol. 120, Issue 1
Cul4A Modulates Invasion and Metastasis of Lung Cancer through Regulation of ANXA10
journal, May 2019
- Hung, Ming-Szu; Chen, Yi-Chuan; Lin, Paul-Yann
- Cancers, Vol. 11, Issue 5
CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition
journal, November 2015
- Pan, Yingfang; Wang, Bo; Yang, Xiaoyun
- Scientific Reports, Vol. 5, Issue 1
Knockdown of CUL4A inhibits invasion and induces apoptosis in osteosarcoma cells
journal, June 2015
- Song, Jia; Zhang, Jing; Shao, Jiang
- International Journal of Immunopathology and Pharmacology, Vol. 28, Issue 2
MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression
journal, June 2016
- Tang, Bo; Lei, Biao; Qi, Guangying
- Journal of Experimental & Clinical Cancer Research, Vol. 35, Issue 1
Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3
journal, February 2019
- Hu, Xiaoyan; Meng, Yang; Xu, Lian
- Cell Death & Disease, Vol. 10, Issue 2
Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas
journal, March 2017
- Yan, Hong; Bi, Lei; Wang, Yunshan
- Scientific Reports, Vol. 7, Issue 1
CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition
journal, November 2015
- Pan, Yingfang; Wang, Bo; Yang, Xiaoyun
- Scientific Reports, Vol. 5, Issue 1
Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression
journal, October 2015
- Ji, Xuening; Jin, Shi; Qu, Xiaotong
- BMC Cancer, Vol. 15, Issue 1
HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma
journal, October 2015
- Lv, Xiupeng; Li, Linlin; Lv, Li
- Journal of Experimental & Clinical Cancer Research, Vol. 34, Issue 1
MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression
journal, June 2016
- Tang, Bo; Lei, Biao; Qi, Guangying
- Journal of Experimental & Clinical Cancer Research, Vol. 35, Issue 1
Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma
journal, December 2015
- Liu, Ting-Ting; You, Huey-Ling; Weng, Shao-Wen
- PLOS ONE, Vol. 10, Issue 12
Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation
journal, October 2015
- Huo, Xiongwei; Li, Suoni; Shi, Tingting
- Oncotarget, Vol. 6, Issue 39
The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications
journal, October 2015
- Sang, Youzhou; Yan, Fan; Ren, Xiubao
- Oncotarget, Vol. 6, Issue 40
Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway
journal, January 2016
- Deng, Jun; Lei, Wan; Xiang, Xiaojun
- Oncotarget, Vol. 7, Issue 9
CUL4A promotes proliferation and metastasis of colorectal cancer cells by regulating H3K4 trimethylation in epithelial–mesenchymal transition
journal, January 2017
- Sui, Xuemei; Zhou, Hong; Zhu, Lei
- OncoTargets and Therapy, Vol. Volume 10
Cul4A Modulates Invasion and Metastasis of Lung Cancer through Regulation of ANXA10
journal, May 2019
- Hung, Ming-Szu; Chen, Yi-Chuan; Lin, Paul-Yann
- Cancers, Vol. 11, Issue 5
Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
journal, July 2016
- Fang, Liping; Zhao, Jiuhan; Wang, Dan
- International Journal of Molecular Medicine, Vol. 38, Issue 3